News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Infliximab Better than Oral DMARDs as Add-On to Methotrexate in Arthritis, Karolinska University Hospital And Karolinska Institute Study


8/7/2009 6:56:38 AM

Bookmark and Share

MedPage Today -- Putting rheumatoid arthritis patients on additional oral disease-modifying drugs when they show poor response to methotrexate in the disease's early stages did not work as well as adding infliximab (Remicade) in an open-label, randomized trial.

Read at HealthDay
Read at MedPageToday
Read at WebMD

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES